Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
This study has been completed.
Study NCT00006348 Information provided by National Cancer Institute (NCI)
First Received: October 4, 2000 Last Updated: November 16, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Lymphoma
Myelodysplastic Syndromes
Nausea and Vomiting
Precancerous/Nonmalignant Condition
Small Intestine Cancer
Additional conditions recognized in this trial
Duodenal Neoplasms
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Multiple Myeloma
Myeloproliferative Disorders
Nausea
Neoplasms
Neoplasms, Plasma Cell
Precancerous Conditions
Preleukemia
Syndrome
Vomiting
More general conditions related to this trial
Blood Protein Disorders
Bone Marrow Diseases
Cardiovascular Diseases
Digestive System Diseases
Digestive System Neoplasms
Disease
Duodenal Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Ileal Diseases
Immune System Diseases
Immunoproliferative Disorders
Intestinal Diseases
Jejunal Diseases
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Paraproteinemias
Pathologic Processes
Signs and Symptoms
Signs and Symptoms, Digestive
Vascular Diseases
Interventions listed in this trial
ondansetron
More general drug interventions related to this trial
Anti-Anxiety Agents
Antiemetics
Antipruritics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dermatologic Agents
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
North Central Cancer Treatment Group
National Cancer Institute (NCI)
Back to top of Main Content
